2026 NPPES data Cardiovascular Disease Physician NPI 1356832893
Verify on CMS →

KHALED ALABDALLAH

Cardiovascular Disease Physician in GALVESTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
344
Medicare Part D claims · 116 beneficiaries · Cardiovascular Disease Physician avg: 3K
Generic prescribing
64%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.5K
26 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: KHALED ALABDALLAH is a Cardiovascular Disease Physician ([object Object]) practicing in GALVESTON, Texas with a Medicare Part D prescribing footprint of 344 claims across 116 beneficiaries — 36% brand-name prescribing . Industry payments of $2.5K across 26 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: KHALED ALABDALLAH filed 344 Medicare Part D claims in 2023 across GALVESTON, Texas. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

KHALED ALABDALLAH practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

KHALED ALABDALLAH at a glance

Quality data not reported

NPI registry status

Active

Issued 05/21/2018

NPI 1356832893

Primary specialty

Cardiovascular Disease Physician

Mid-sized

24,795 US NPIs in this specialty

Medicare Part D claims

344 89% vs specialty avg

2023 prescription claims

Specialty avg: 3,033

Specialty distribution in Texas

How Cardiovascular Disease Physician compares to other specialties among Texas providers

Texas providers

Cardiovascular Disease Physician share within Texas

1. Cardiovascular Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Cardiovascular Disease Physician share within Texas

Specialty board-certification context

Estimated specialty board-certified rate — Cardiovascular Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Cardiovascular Disease Physician ABMS/AOA estimate

Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Cardiovascular Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KHALED ALABDALLAH is a Cardiovascular Disease Physician provider practicing in GALVESTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1356832893. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KHALED ALABDALLAH appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider at 301 8TH ST, GALVESTON, TX, 77555, with a listed phone of (409) 772-1011. NPI 1356832893 was issued on 05/21/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALABDALLAH most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 344 prescription claims written by this provider, covering 116 Medicare beneficiaries and totaling roughly $86K in drug spend, split 36% brand-name and 64% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

301 8TH ST
GALVESTON, TX 77555

Provider Details

NPI 1356832893
Specialty Cardiovascular Disease Physician
Gender Male
NPI Issued 05/21/2018

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KHALED ALABDALLAH. Source: openpaymentsdata.cms.gov.

Total received

$2.5K

Largest payer

Abbott Laboratories

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to KHALED ALABDALLAH. To verify KHALED ALABDALLAH's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

KHALED ALABDALLAH — brand share 36.0%
Specialty average (est.)

36% brand-name claims vs 64% generic, on 344 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

344
Total Claims
$86K
Total Drug Cost
116
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
546
Total Day Supply
15,224
Brand vs Generic
36% brand / 64% generic
Brand Drug Cost
$82K
Generic Drug Cost
$4K
Antibiotic Claims
30

Patient Demographics

Average Patient Age
74.4 years
Avg HCC Risk Score
2.31
Gender Split
47% female / 53% male
Age Distribution
<65: 17, 65-74: 39, 75-84: 37, 85+: 23

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Eliquis
Apixaban
56
Furosemide
46
Jardiance
Empagliflozin
37
Metoprolol Succinate
31
Spironolactone
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Cardiovascular Disease Physician Overview

How KHALED ALABDALLAH fits within the Cardiovascular Disease Physician landscape nationally.

24,795
Cardiovascular Disease Physician Providers in US
54
States with Cardiovascular Disease Physician
3,033
Avg Claims per Provider

KHALED ALABDALLAH's 344 claims are below the specialty average of 3,033.

Nearby Cardiovascular Disease Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ALABDALLAH.

Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KHALED ALABDALLAH's specialty?
KHALED ALABDALLAH specializes in Cardiovascular Disease Physician and practices in GALVESTON, Texas.
How much does KHALED ALABDALLAH prescribe under Medicare Part D?
In 2023, KHALED ALABDALLAH wrote 344 Medicare Part D claims totaling $86K in drug costs for 116 beneficiaries.
Where is KHALED ALABDALLAH located?
KHALED ALABDALLAH is located at 301 8TH ST, GALVESTON, TX, 77555. Phone: (409) 772-1011.
What is KHALED ALABDALLAH's NPI number?
KHALED ALABDALLAH's National Provider Identifier (NPI) is 1356832893, issued on 05/21/2018.
Does KHALED ALABDALLAH prescribe more brand-name or generic drugs?
KHALED ALABDALLAH's prescribing is 36% brand-name and 64% generic drugs by claim count, with $82K in brand drug costs.
How many Cardiovascular Disease Physician providers are there in the US?
There are 24,795 Cardiovascular Disease Physician providers across 54 states in the US. The average Cardiovascular Disease Physician provider writes 3,033 Medicare Part D claims per year.
What drugs does KHALED ALABDALLAH prescribe most often?
Based on 2023 Medicare Part D data, KHALED ALABDALLAH's most frequently prescribed drugs include Eliquis, Furosemide, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KHALED ALABDALLAH accept Medicare?
KHALED ALABDALLAH appears in CMS Medicare data with 344 Part D claims and 116 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KHALED ALABDALLAH's credentials?
KHALED ALABDALLAH's NPI is 1356832893. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology